Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes

Leukemia

Volumn 27, Issue 10, 2013, Pages 2107-2111

  Suzuki, H I ^a   Matsuyama, H ^a   Noguchi, M ^b   Yao, T ^c   Komatsu, N ^d   Mano, H ^a,e   Sugimoto, K ^d,f   Miyazono, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f JR Tokyo General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MESSENGER RNA; MICRORNA; MICRORNA 106A; MICRORNA 155; MICRORNA 17 92; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; BREAST CANCER; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; LARGE CELL LYMPHOMA; LETTER; MICROARRAY ANALYSIS; PERIPHERAL T CELL LYMPHOMA; PREDICTION; PRIORITY JOURNAL; RNA EXTRACTION;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84885660636     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.121     Document Type: Letter

References (15)

1. Schotte D, Pieters R, Den Boer ML. MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 2012; 26: 1-12.
2. Akbari Moqadam F, Pieters R, den Boer ML. The hunting of targets: challenge in miRNA research. Leukemia 2013; 27: 16-23.
3. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012; 13: 358-369.
4. Callari M, Dugo M, Musella V, Marchesi E, Chiorino G, Grand MM et al. Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 2012; 7: e45105.
5. Suzuki HI, Mihira H, Watabe T, Sugimoto K, Miyazono K. Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis. Nucleic Acids Res 2013; 41: e62.
6. Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK) and ALK-anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2010; 107: 16228-16233.
7. Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011; 117: 6627-6637.
8. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 2011; 118: 6881-6892.
9. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 1026-1036.
10. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012; 21: 121-135.
11. Ralfkiaer U, Hagedorn PH, Bangsgaard N, Lovendorf MB, Ahler CB, Svensson L et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011; 118: 5891-5900.
12. Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007; 117: 823-834.
13. Li HH, Cai X, Shouse GP, Piluso LG, Liu X. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J 2007; 26: 402-411.
14. Cui YX, Kerby A, McDuff FK, Ye H, Turner SD. NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner. Blood 2009; 113: 5217-5227.
15. Png KJ, Halberg N, Yoshida M, Tavazoie SF. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2012; 481: 190-194.